Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 2 mins

The impact of dexmedetomidine on postoperative delirium and early postoperative cognitive impairment in elderly patients undergoing general surgery: a systematic review and meta-analysis

AI Summary
  • Dexmedetomidine significantly reduced 24-h postoperative delirium and early cognitive impairment versus control (pooled OR 0.38, 95% CI 0.24-0.61; p < 0.001).
  • Typical regimen used: 1 µg/kg loading dose followed by intraoperative infusion of 0.2-0.7 µg/kg/h across included studies.
  • Evidence limited to four trials (479 patients); larger, long-term studies needed to confirm benefits and establish standardised dosing protocols.
Summarise with AI (MRCPsych/FRANZCP)

J Anesth. 2026 Oct 22. doi: 10.1007/s00540-026-03927-1. Online ahead of print.

ABSTRACT

Anesthetic management in general surgery poses substantial risks in elderly patients because age-related physiologic decline and preexisting comorbidities increase vulnerability to peri-operative complications. Older adults have reduced physiological reserve, impaired organ function, and slower recovery from surgical and anesthetic stress, placing them at increased risk for postoperative delirium and early postoperative cognitive impairment. Dexmedetomidine, a selective α2-adrenergic receptor agonist, has sedative, anti-inflammatory, and opioid-sparing properties that may influence early postoperative cognitive outcomes without significant respiratory depression. This systematic review and meta-analysis evaluated the association between dexmedetomidine and 24-h postoperative delirium/early postoperative cognitive impairment in elderly patients undergoing general surgery. Four studies involving 479 patients met the inclusion criteria. Across the included studies, dexmedetomidine was generally administered as a 1 µg/kg loading dose followed by continuous intraoperative maintenance infusion of 0.2-0.7 µg/kg/h. Pooled analysis showed that dexmedetomidine was associated with significantly lower odds of 24-h postoperative delirium/early postoperative cognitive impairment compared with control treatment (pooled OR 0.38, 95% CI 0.24-0.61; p < 0.001). These findings suggest that dexmedetomidine is associated with lower odds of early postoperative cognitive outcomes in elderly surgical patients compared with control treatment. Larger, long-term studies are needed to confirm these findings and establish standardized dosing protocols.

PMID:42918904 | DOI:10.1007/s00540-026-03927-1

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD